Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals

@article{Zanchi2010EffectsOT,
  title={Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals},
  author={Anne Zanchi and Marc P. Maillard and François R Jornayvaz and Manlio Vinciguerra and Patrik Del{\'e}aval and Juerg Nussberger and Michel Antoine Burnier and Antoinette P{\'e}ch{\`e}re-Bertschi},
  journal={Diabetologia},
  year={2010},
  volume={53},
  pages={1568-1575}
}
Glitazones are powerful insulin sensitisers prescribed for the treatment of type 2 diabetes. Their use is, however, associated with fluid retention and an increased risk of congestive heart failure. We previously demonstrated that pioglitazone increases proximal sodium reabsorption in healthy volunteers. This study examines the effects of pioglitazone on renal sodium handling in individuals prone to insulin resistance, i.e. those with diabetes and/or hypertension. In this double-blind… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES

Similar Papers

Loading similar papers…